CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI1C2
| Applications | ELISA, Neutralize |
| Reactivities | SARS-CoV-2 |
Primary Antibodies
CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI4C6
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI12G4
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI7F6
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI6A12
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
2周
SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI11G1
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
2周
SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI4H5
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI3H6
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI1C2
| Applications | ELISA, Neutralize |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 N protein mouse monoclonal antibody, clone OTI4B9
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI3H6
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI4C6
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI3A2
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 N Protein Mouse Monoclonal Antibody, Clone OTI10B2
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
CNY 1999.00
CNY 3600.00
现货
SARS-CoV-2 N protein mouse monoclonal antibody, clone OTI4F8
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
